Prof. Valery Krizhanovsky's project was approved by Bina nurture committee

We are excited to share that the Bina committee has approved a project led by Prof. Valery Krizhanovsky, which focuses on exploring the therapeutic effects of novel bi-specific antibodies on senescence in cancer.
These innovative antibodies will be developed at the Weizmann Institute of Science's Life Science Core Facilities under the direction of Dr. Ira Zaretsky, with project guidance provided by Dr. Merav Marom from Bina and Dr. Yael Klionsky from YEDA - Technology Transfer Company of Weizmann Institute of Science.